PMS2 and colorectal cancer: The two protein losses have been far the most frequent in the dMMR cohort (70%) and the PCR discrepancy was the lowest in case of the MLH1/PMS2 phenotype in case of the colorectal cancers exclusively (Additional file 1: Table S6).